RETRACTED: Therapy targeted at vascular endothelial growth factor in metastatic renal cell carcinoma: biology, clinical results and future development (Retracted article. See vol. 109, pg. E43, 2012)

被引：42

作者：

Rini, BI

Sosman, JA

Motzer, RJ

机构：

[1] Cleveland Clin Fdn, Taussig Canc Ctr, Cleveland, OH 44195 USA

[2] Vanderbilt Ingram Canc Ctr, Nashville, TN USA

[3] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA

来源：

BJU INTERNATIONAL | 2005年 / 96卷 / 03期

关键词：

RCC; VEGF; VHL; bevacizumab; SU11248; BAY; 43-9006;

D O I：

10.1111/j.1464-410X.2005.05616.x

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：286 / 290

页数：5

共 34 条

[1] Selective ablation of immature blood vessels in established human tumors follows vascular endothelial growth factor withdrawal [J].

Benjamin, LE ;

Golijanin, D ;

Itin, A ;

Pode, D ;

Keshet, E .

JOURNAL OF CLINICAL INVESTIGATION, 1999, 103 (02) :159-165

[2]

Bukowski R M, 2001, Semin Urol Oncol, V19, P148

[3] Hypoxia inducible factor-α binding and ubiquitylation by the von Hippel-Lindau tumor suppressor protein [J].

Cockman, ME ;

Masson, N ;

Mole, DR ;

Jaakkola, P ;

Chang, GW ;

Clifford, SC ;

Maher, ER ;

Pugh, CW ;

Ratcliffe, PJ ;

Maxwell, PH .

JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (33) :25733-25741

[4] Role of transforming growth factor-α in von Hippel-Lindau (VHL)-/- clear cell renal carcinoma cell proliferation:: A possible mechanism coupling VHL tumor suppressor inactivation and tumorigenesis [J].

de Paulsen, N ;

Brychzy, A ;

Fournier, MC ;

Klausner, RD ;

Gnarra, JR ;

Pause, A ;

Lee, S .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (04) :1387-1392

[5] Vascular permeability factor/vascular endothelial growth factor: A critical cytokine in tumor angiogenesis and a potential target for diagnosis and therapy [J].

Dvorak, HF .

JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (21) :4368-4380

[6]

DVORAK HF, 1979, J IMMUNOL, V122, P166

[7]

DVORAK HF, 1995, AM J PATHOL, V146, P1029

[8] The biology of vascular endothelial growth factor [J].

Ferrara, N ;

DavisSmyth, T .

ENDOCRINE REVIEWS, 1997, 18 (01) :4-25

[9] Nephrectomy followed by interferon alfa-2b compared with interferon alfa-2b alone for metastatic renal-cell cancer [J].

Flanigan, RC ;

Salmon, SE ;

Blumenstein, BA ;

Bearman, SI ;

Roy, V ;

McGrath, PC ;

Caton, JR ;

Munshi, N ;

Crawford, ED .

NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (23) :1655-1659

[10]

Friberg G, 2004, J CLIN ONCOL, V22, p140S

← 1 2 3 4 →